bioRxivNeurosciencePreprint
TIMELINE OF BRAIN ALTERATIONS IN ALZHEIMER’S DISEASE ACROSS THE ENTIRE LIFESPAN
Pierrick Coupé AiD, José V. ManjóniD, Enrique LanuzaiD, Gwénaëlle CathelineiD, Alzheimer’s Disease Neuroimaging Initiative
Abstract
Brain imaging studies have shown that progressive cerebral atrophy characterized the development of Alzheimers Disease (AD). The key question is how long before the diagnosis of AD the neurodegenerative process started leading to these structural alterations. To answer this question, we proposed an innovative way by inferring brain structure volume trajectories across the entire lifespan using massive number of MRI (N=4714). Our study provides evidences of early divergence of the AD model from the control model for the hippocampus before 40 years, followed by the lateral ventricles and the amygdala around 40 years for the AD model. Moreover, our lifespan investigation reveals the dynamic of the evolution of these biomarkers and suggest close abnormality trajectories for the hippocampus and the amygdala. Finally, our results highlight that the temporal lobe atrophy, a key biomarker in AD, is a very early pathophysiological event potentially associated to early life exposures to risk factors.
- organism: human
- assay: imaging
- research focus: trajectory inference
- research focus: differential expression
- research focus: spatial domain detection
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Investigating the temporal pattern of neuroimaging-based brain age estimation as a biomarker for Alzheimer's Disease related neurodegeneration
Alexei Taylor, Fengqing Zhang, … the Alzheimer’s Disease Neuroimaging Initiative·NeuroImagePeer-reviewed·Sep 9, 2022
- Normative brain-state trajectories reveal deviation from healthy aging in Alzheimer's disease
Monireh Taimouri, Vikram Ravindra·bioRxiv·Jun 24, 2026
- Divergent amyloid trajectories distinguish normal aging from Alzheimer's disease progression
Mingzhao Tong, Tianchuan Gao, … Alzheimer’s Disease Neuroimaging Initiative·bioRxiv·Sep 14, 2026
- Identifying Changepoints in Biomarkers During the Preclinical Phase of AD
Laurent Younes B, Marilyn Albert, … Michael I. Miller·Frontiers in Aging NeurosciencePeer-reviewed·Apr 2, 2019
- Hippocampal sclerosis of aging at post-mortem is evident on MRI more than a decade prior
Diana Ortega‐Cruz, Juan Eugenio Iglesias, … Bryan Andrew Strange·Alzheimer s & DementiaPeer-reviewed·Jun 27, 2023
- Predicting time to dementia using a quantitative template of disease progression
Murat Bilgel, Bruno Jedynak, Alzheimer’s Disease Neuroimaging Initiative·Alzheimer s & Dementia Diagnosis Assessment & Disease MonitoringPeer-reviewed·Feb 27, 2019